PD Journal Club Meeting
With Leon Meytin, M.D.
Friday, July 30th 8:30am
We will be discussing the new classes of drugs that is in clinical trials, the alpha synuclein antibody drugs (similar to the Alzheimer’s drug that just got approved).
There isn’t a recent published article about it but its in phase 2b trials now and actually recruiting patients.